• Latest Posts

Samsung Bioepis Submits a Biosimilar Candidate, to the European Medicines Agency

First Treatment Approved under Early Access to Medicine Scheme (EAMS)

Adimab, the secret weapon of the Big Pharma companies

An Effective Renewed Partnership for Treatment of Gynecological Cancers

A new way to develop therapeutic monoclonal antibodies against Cancer